BIOTECanada's Andrew Casey on the Future of Canadian Biotech

In an interview with Life Science Investing News, BIOTECanada's Andrew Casey offers his take on the sector going into 2017.

$500M Biotech Venture Fund to Be Based in Vancouver

Canadian venture capital company Quark and a Chinese investment bank, GF Securities, announced on October 17, 2016 that they have...

3 Ways to Invest in Biotech

Here's a look at three ways to invest in biotech, including the pros and cons of each.

Canadian Biotech Industry Recognizes Top Performers

OTTAWA, Ontario–(BUSINESS WIRE)–BIOTECanada is pleased to announce the 2016 winners in two BIOTECanada Gold Leaf Award categories- Emerging Company of...

Why Should I Invest in Biotech?

There are gains to be made in the biotech market, but investors must be savvy about which high-risk ventures to...